Skip to content
Search

Latest Stories

DHSC grants final November price concessions

The Pharmaceutical Services Negotiating Committee has announced that the Department of Health and Social Care (DHSC) has granted final price concessions to further items for the month of November 2021.

DrugPack sizePrice Concession
Co-amilozide 5mg/50mg tablets28£8.98
Co-dydramol 10mg/500mg tablets100£6.19
Co-dydramol 10mg/500mg tablets30£1.86
Omeprazole 10mg/5ml oral suspension sugar free75£106.46
Omeprazole 20mg/5ml oral suspension sugar free75£206.00
Prednisolone 5mg soluble tablets30£10.35
Simvastatin 20mg/5ml oral suspension sugar free150£173.89
Simvastatin 40mg/5ml oral suspension sugar free150£250.63
Sulfasalazine 500mg gastro-resistant tablets112£23.12
Sulfasalazine 500mg tablets112£21.35
Topiramate 100mg tablets60£8.09
Topiramate 25mg tablets60£2.89
Topiramate 50mg tablets60£3.52
Trazodone 100mg capsules56£3.50
Trazodone 150mg tablets28£3.31

The DHSC previously announced (26.11.2021) the following list of price concessions:


DrugPack sizePrice Concession
Amisulpride 50mg tablets60£2.99
Donepezil 1mg/ml oral solution sugar free150£81.23
Ivabradine 5mg tablets56£7.87
Lercanidipine 20mg tablets28£3.04
Metformin 500mg/5ml oral solution sugar free150£36.15
Mirtazapine 15mg/ml oral solution sugar free66£97.89
Orphenadrine 50mg/5ml oral solution sugar free150£87.09
Procyclidine 2.5mg/5ml oral solution sugar free150£37.39
Procyclidine 5mg/5ml oral solution sugar free150£55.61
Promazine 25mg/5ml oral solution150£60.19
Promazine 50mg/5ml oral solution150£75.36
Quetiapine 20mg/ml oral suspension sugar free150£166.31
Ramipril 2.5mg/5ml oral solution sugar free150£164.12
Ropinirole 1mg tablets84£56.71
Sodium fluoride 0.05% mouthwash sugar free250£1.57
Sulfasalazine 250mg/5ml oral suspension sugar free500£94.22
Tamoxifen 10mg/5ml oral solution sugar free150£74.52
Timolol 0.25% eye drops5£3.73
Trihexyphenidyl 5mg/5ml oral solution200£82.54
Trimethoprim 100mg tablets28£2.10
Warfarin 1mg/ml oral suspension sugar free150£156.07

The DHSC previously announced (19.11.2021) the following list of price concessions:

DrugPack sizePrice Concession
Celecoxib 100mg capsules60£1.80
Celecoxib 200mg capsules30£1.75
Cinnarizine 15mg tablets84£3.97
Clomipramine 10mg capsules28£2.76
Clomipramine 25mg capsules28£4.85
Clomipramine 50mg capsules28£8.25
Enalapril 10mg tablets28£5.29
Enalapril 5mg tablets28£7.15
Fludrocortisone 100microgram tablets30£11.20
Lamotrigine 5mg dispersible tablets sugar free28£8.35
Lansoprazole 30mg orodispersible tablets28£5.18
Lercanidipine 10mg tablets28£2.99
Loratadine 5mg/5ml oral solution100£6.46
Methocarbamol 750mg tablets100£12.95
Naftidrofuryl 100mg capsules84£7.79
Nitrofurantoin 50mg capsules30£10.49
Orlistat 120mg capsules84£24.22
Pioglitazone 30mg tablets28£2.70
Pioglitazone 45mg tablets28£2.70
Timolol 0.5% eye drops5£3.77
Tolbutamide 500mg tablets28£25.75
Tolterodine 1mg tablets56£3.46
Tolterodine 2mg tablets56£4.82
Trazodone 50mg capsules84£3.45
Trimethoprim 50mg/5ml oral suspension sugar free100£10.75
Ursodeoxycholic acid 250mg capsules60£10.27

A price concession only applies for the month in which it is granted. No additional prescription endorsement are required as the new price is automatically applied by the NHS BSA to all items submitted for payment in the same month for which a price concession is granted.

Contractors can find information and learn about the process involved on PSNC’s website.

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less